# Onto Innovation Inc.: overview

ONTO · NYSE · CIK 704532 · [Technology](/sectors/technology.md) · fiscal year ends Dec 26

Pages: [Overview](/companies/onto.md) · [Financials](/companies/onto/financials.md) · [Filings](/companies/onto/filings.md) · [Insiders](/companies/onto/insiders.md)

Latest reported revenue: [$343.1m](/filings/0001193125-26-338401.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 6, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001193125-26-338401).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-28) | Q4 FY2024 (2024-12-28) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | Q4 FY2025 (2026-01-03) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [252](/filings/0001193125-25-270040.md) | [264 d](/filings/0001193125-26-066937.md) | [267](/filings/0001193125-26-206707.md) | [254](/filings/0001193125-26-338401.md) | [218](/filings/0001193125-25-270040.md) | [267 d](/filings/0001193125-26-066937.md) | [292](/filings/0001193125-26-206707.md) | [343](/filings/0001193125-26-338401.md) |
| Gross margin | % | [54.1%](/filings/0001193125-25-270040.md) | [50.2% d](/filings/0001193125-26-066937.md) | [53.7%](/filings/0001193125-26-206707.md) | [48.2%](/filings/0001193125-26-338401.md) | [50.7%](/filings/0001193125-25-270040.md) | [46.4% d](/filings/0001193125-26-066937.md) | [50.1%](/filings/0001193125-26-206707.md) | [53.4%](/filings/0001193125-26-338401.md) |
| Operating margin | % | [21.0%](/filings/0001193125-25-270040.md) | [16.1% d](/filings/0001193125-26-066937.md) | [23.7%](/filings/0001193125-26-206707.md) | [12.7%](/filings/0001193125-26-338401.md) | [10.9%](/filings/0001193125-25-270040.md) | [5.2% d](/filings/0001193125-26-066937.md) | [11.5%](/filings/0001193125-26-206707.md) | [18.5%](/filings/0001193125-26-338401.md) |
| Net margin | % | [21.0%](/filings/0001193125-25-270040.md) | [18.5% d](/filings/0001193125-26-066937.md) | [24.0%](/filings/0001193125-26-206707.md) | [13.4%](/filings/0001193125-26-338401.md) | [12.9%](/filings/0001193125-25-270040.md) | [3.9% d](/filings/0001193125-26-066937.md) | [11.6%](/filings/0001193125-26-206707.md) | [17.5%](/filings/0001193125-26-338401.md) |
| Diluted EPS | $ per share | [1.07](/filings/0001193125-25-270040.md) | not reported | [1.30](/filings/0001193125-26-206707.md) | [0.69](/filings/0001193125-26-338401.md) | [0.57](/filings/0001193125-25-270040.md) | not reported | [0.67](/filings/0001193125-26-206707.md) | [1.21](/filings/0001193125-26-338401.md) |
| Free cash flow | $m | [59.2 d](/filings/0001193125-25-270040.md) | [51.4 d](/filings/0001193125-26-066937.md) | [83.7](/filings/0001193125-26-206707.md) | [44.2 d](/filings/0001193125-26-338401.md) | [82.0 d](/filings/0001193125-25-270040.md) | [89.9 d](/filings/0001193125-26-066937.md) | [22.7](/filings/0001193125-26-206707.md) | [57.9 d](/filings/0001193125-26-338401.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2022-01-01) | FY2022 (2022-12-31) | FY2023 (2023-12-30) | FY2024 (2024-12-28) | FY2025 (2026-01-03) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [789](/filings/0000950170-24-020150.md) | [1,005](/filings/0000950170-25-026729.md) | [816](/filings/0001193125-26-066937.md) | [987](/filings/0001193125-26-066937.md) | [1,005](/filings/0001193125-26-066937.md) |
| Gross margin | % | [54.4%](/filings/0000950170-24-020150.md) | [53.6%](/filings/0000950170-25-026729.md) | [51.5%](/filings/0001193125-26-066937.md) | [52.2%](/filings/0001193125-26-066937.md) | [49.7%](/filings/0001193125-26-066937.md) |
| Operating margin | % | [(19.8%)](/filings/0000950170-24-020150.md) | [23.5%](/filings/0000950170-25-026729.md) | [14.2%](/filings/0001193125-26-066937.md) | [19.0%](/filings/0001193125-26-066937.md) | [13.2%](/filings/0001193125-26-066937.md) |
| Net margin | % | [18.0%](/filings/0000950170-24-020150.md) | [22.2%](/filings/0000950170-25-026729.md) | [14.9%](/filings/0001193125-26-066937.md) | [20.4%](/filings/0001193125-26-066937.md) | [13.6%](/filings/0001193125-26-066937.md) |
| Diluted EPS | $ per share | [2.86](/filings/0000950170-24-020150.md) | [4.49](/filings/0000950170-25-026729.md) | [2.46](/filings/0001193125-26-066937.md) | [4.06](/filings/0001193125-26-066937.md) | [2.78](/filings/0001193125-26-066937.md) |
| Free cash flow | $m | [163](/filings/0000950170-24-020150.md) | [118](/filings/0000950170-25-026729.md) | [149](/filings/0001193125-26-066937.md) | [214](/filings/0001193125-26-066937.md) | [300](/filings/0001193125-26-066937.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/onto/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $2.08bn | 5,505,181 |  | Reduced −29,084 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $1.03bn | 2,727,910 |  | Reduced −15,109 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $850.7m | 2,247,737 |  | Added +24,885 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $588.1m | 1,554,825 |  | Added +55,141 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $542.7m | 1,433,715 |  | Added +222,701 |
| [Invesco Ltd.](/funds/914208.md) | 2026-06-30 | $511.6m | 1,351,886 |  | Added +719,083 |
| [PARADIGM CAPITAL MANAGEMENT INC/NY](/funds/1037792.md) | 2026-06-30 | $416.8m | 1,101,438 |  | Reduced −1,000 |
| [Point72 Asset Management, L.P.](/funds/1603466.md) | 2026-06-30 | $367.9m | 972,161 |  | Reduced −231,497 |
| [FMR LLC](/funds/315066.md) | 2026-06-30 | $334.3m | 883,298 |  | Added +54,321 |
| [VOYA INVESTMENT MANAGEMENT LLC](/funds/1068837.md) | 2026-06-30 | $284.8m | 753,768 |  | Reduced −163,387 |

## Recent filings

[All 1,422 filings](/companies/onto/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-10 | 12:16 ET | [8-K](/filings/0001193125-26-341337.md) | 2.01 Completion of an acquisition or disposition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-341337 |
| 2026-08-06 | 21:03 ET | [10-Q](/filings/0001193125-26-338401.md) | Quarterly report, period 2026-06-30 | 0001193125-26-338401 |
| 2026-08-06 | 20:09 ET | [8-K](/filings/0001193125-26-337990.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-337990 |
| 2026-05-21 | 20:38 ET | [8-K](/filings/0001193125-26-234610.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-234610 |
| 2026-05-20 | 20:01 ET | [8-K](/filings/0001193125-26-232522.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-232522 |
| 2026-05-18 | 11:53 ET | [8-K](/filings/0001193125-26-227915.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-227915 |
| 2026-05-05 | 21:01 ET | [10-Q](/filings/0001193125-26-206707.md) | Quarterly report, period 2026-03-31 | 0001193125-26-206707 |
| 2026-05-05 | 20:06 ET | [8-K](/filings/0001193125-26-206365.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-206365 |
| 2026-04-21 | 23:23 ET | [8-K](/filings/0001193125-26-164529.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-164529 |
| 2026-04-16 | 13:02 ET | [8-K](/filings/0001193125-26-158081.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-158081 |

## Latest annual report

[Form 10-K for the fiscal year ended Jan 3, 2026](/filings/0001193125-26-066937.md), filed Feb 24, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/1b1010da-aad2-498b-9594-09c206d23d36)

## About the filer

- CIK: 704532
- Tickers: ONTO
- Exchange: NYSE
- SIC code: 3829 Measuring & Controlling Devices, NEC
- State of incorporation: DE
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:22 ET. No prices; not investment advice.